about
Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrowPost-tonsillectomy bleeding in children with von Willebrand disease: a single-institution experience.Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).Plasma copeptin and the risk of diabetes mellitus.Rab27a and MyRIP regulate the amount and multimeric state of VWF released from endothelial cells.Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha.The clinical efficacy and safety of the FVIII/VWF concentrate, BIOSTATE®, in children with von Willebrand disorder: a multi-centre retrospective review.When von Willebrand disease comes into age - a matter of change?Inherited disorders of blood coagulation.Current management of patients with severe von Willebrand disease type 3: a 2012 update.The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story.Safety of a pasteurized plasma-derived Factor VIII and von Willebrand factor concentrate: analysis of 33 years of pharmacovigilance data.Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease.Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.Guidelines for the management of hemophilia.
P2860
Q33381047-77F96215-0155-4DDF-951C-75B4677B048BQ35744451-740131FE-F941-4C6D-BED7-30679D560106Q35887945-FE685798-94FF-4538-94C4-CA003CA74005Q37147707-30652A13-6172-48FF-B110-55124599BA2AQ37201909-78E27637-F536-41F0-A713-EC82FC14D022Q37263295-8F52E421-60B2-4B42-890F-CD5F7E789B77Q37813807-A8B45C83-40A0-4E76-949D-56178708BD2EQ37854842-4CC947F9-3689-4CAA-8B67-6707125031B5Q37876411-9ED43FD4-0C90-40C0-A2F0-45BE7A8BA53AQ38020749-BFCFCB3B-AE55-4434-9586-0D45CC19D860Q38117737-ED605B9C-A928-40D8-8533-818CE0668F26Q38687056-D742C0EA-1D5C-4D79-9CFA-0CD0E9E255F2Q43137286-AF67A206-2A00-4CF5-AA49-79688668D05AQ45875643-DB20B5B1-8A17-460C-9538-3D3E1397AECDQ45880345-5C9922BF-8A41-4B99-95B3-97954002E54D
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Management of inherited von Willebrand disease in 2007.
@en
type
label
Management of inherited von Willebrand disease in 2007.
@en
prefLabel
Management of inherited von Willebrand disease in 2007.
@en
P2860
P1433
P1476
Management of inherited von Willebrand disease in 2007.
@en
P2093
Augusto B Federici
P2860
P304
P356
10.1080/07853890701513738
P407
P577
2007-01-01T00:00:00Z